China National Medicines Corporation Ltd. Stock

Equities

600511

CNE000001D56

Pharmaceuticals

End-of-day quote Shanghai S.E. 06:00:00 2024-04-18 pm EDT 5-day change 1st Jan Change
35.78 CNY +1.13% Intraday chart for China National Medicines Corporation Ltd. +7.13% +25.02%
Sales 2024 * 54.08B 7.47B Sales 2025 * 59.99B 8.29B Capitalization 27B 3.73B
Net income 2024 * 2.36B 326M Net income 2025 * 2.65B 366M EV / Sales 2024 * 0.5 x
Net cash position 2024 * - 0 Net cash position 2025 * - 0 EV / Sales 2025 * 0.45 x
P/E ratio 2024 *
11.5 x
P/E ratio 2025 *
10.2 x
Employees -
Yield 2024 *
2.57%
Yield 2025 *
2.81%
Free-Float 42.95%
More Fundamentals * Assessed data
Dynamic Chart
1 day+1.13%
1 week+7.13%
Current month+8.42%
1 month+20.55%
3 months+22.79%
6 months+18.09%
Current year+25.02%
More quotes
1 week
33.63
Extreme 33.63
36.00
1 month
30.93
Extreme 30.93
36.00
Current year
27.18
Extreme 27.18
36.00
1 year
26.58
Extreme 26.58
44.80
3 years
24.36
Extreme 24.36
44.80
5 years
21.12
Extreme 21.12
62.95
10 years
19.00
Extreme 19
62.95
More quotes
Managers TitleAgeSince
Chief Executive Officer 54 21-07-31
Director of Finance/CFO 49 23-10-13
Chairman 60 99-11-30
Members of the board TitleAgeSince
Director/Board Member 48 22-04-06
Chairman 60 99-11-30
Director/Board Member 66 22-04-06
More insiders
Date Price Change Volume
24-04-19 35.78 +1.13% 5,492,935
24-04-18 35.38 -0.23% 5,015,079
24-04-17 35.46 +1.43% 6,686,375
24-04-16 34.96 -0.03% 7,345,911
24-04-15 34.97 +4.70% 9,580,432

End-of-day quote Shanghai S.E., April 18, 2024

More quotes
China National Medicines Corporation Ltd. is a China-based company principally engaged in the distribution of pharmaceutical products. The Company's primary products include proprietary Chinese medicines, chemical medicine preparations, chemical raw materials, antibiotics, biochemical drugs, biological products, narcotic drugs, psychotropic drugs, vaccines and health foods, among others. The Company is also involved in the production of pharmaceuticals and the provision of warehousing services through its subsidiaries.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
35.78 CNY
Average target price
42.3 CNY
Spread / Average Target
+18.22%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. 600511 Stock